Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00837681 · ClinicalTrials.gov registry record

Pulmonary Complications of Hematopoietic Stem Cell Transplantation

A clinical trial of Lung Disease, sponsored by Karen Wood.

Completed
Registry status
350
Enrollment target
1
Study location

NCT00837681: Completed study of Lung Disease, sponsored by Karen Wood.

NCT00837681 is a study of Lung Disease that has completed, run by Karen Wood. The registered enrollment target is 350 participants, below the 987-participant average among 3 other Lung Disease trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00837681, a study of Lung Disease, has completed, sponsored by Karen Wood.

COMPLETED
Registry status
350 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine risk factors associated with the development of lung disease after hematopoietic stem cell transplantation. Depending on the results and findings of this study, it may be possible to predict who is at higher risk of serious complications and ultimately develop therapies to prevent or treat this lung disease.

Conditions Studied

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2005-10
Est. Completion 2016-07-08
Karen Wood

3 total trials

What the finished NCT00837681 record still lists

NCT00837681 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 987-participant average among 3 other Lung Disease trials with a reported enrollment target (65% lower).

The record links to 1 condition, with Lung Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00837681 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00837681 about?

NCT00837681 is a clinical study titled "Pulmonary Complications of Hematopoietic Stem Cell Transplantation". The purpose of this study is to determine risk factors associated with the development of lung disease after hematopoietic stem cell transplantation. Depending on the results and findings of this study, it may be possible to predict who is at higher risk of serious complications and ultimately devel...

What is the current status of trial NCT00837681?

This trial is currently completed. The enrollment target is 350 participants. The study started on 2005-10. Estimated completion is 2016-07-08.

What conditions does trial NCT00837681 study?

This clinical trial studies the following conditions: Lung Disease.

Who is sponsoring clinical trial NCT00837681?

This trial is sponsored by Karen Wood, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00837681 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00837681, the US trial registry maintained by the National Library of Medicine. NCT00837681 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.